title: The Potential Value of Near Patient Platelet Function Testing in PCI: Randomised Comparison of 600 mg versus 900 mg Clopidogrel Loading Doses.
abstract: Whilst poor response to clopidogrel is associated with adverse outcomes uncertainty exists as to how (a) response should be assessed and (b) poor responders managed. We utilised VerifyNow P2Y12 and short Thrombelastography (TEG) to assess 900 mg doses in (i) initial poor responders to 600 mg and (ii) in a randomised comparison with 600 mg. Blood was taken before and six hours post clopidogrel in (i) 30 volunteers receiving 600 mg (poor responders received 900 mg > two weeks later) and (ii) 60 patients randomized 1 : 1 to 600 mg or 900 mg doses. Poor response was defined as TEG %Clotting Inhibition (%CIn) or VerifyNow Platelet Response Unit (PRU) reduction <30%. (i) Poor responders to 600 mg had greater PRU reduction (45.0 versus 20.1%, P = 0.03) and greater %CIn (22.9 versus -15.1%, P = 0.01) after 900 mg but (ii) there were no significant differences between the patient groups. Near-patient assessment of response to clopidogrel is feasible and clinically useful. Whilst ineffective on a population basis 900 mg doses increase the effect of clopidogrel in initial poor responders.
authors.affiliation: Cardiac Intervention Unit, Royal Bournemouth Hospital, Castle Lane East, Bournemouth, BH7 7DW, UK.
authors.forename: Alex R
authors.initials: AR
authors.lastname: Hobson
authors.forename: Zeshan
authors.initials: Z
authors.lastname: Qureshi
authors.forename: Phil
authors.initials: P
authors.lastname: Banks
authors.forename: Nicholas
authors.initials: N
authors.lastname: Curzen
references.citation: J Am Coll Cardiol. 2006 Sep 5;48(5):931-8
references.pmid: 16949482
references.citation: Thromb Haemost. 2008 Feb;99(2):357-62
references.pmid: 18278186
references.citation: Thromb Haemost. 2007 Oct;98(4):838-43
references.pmid: 17938809
references.citation: Circulation. 2007 Feb 13;115(6):708-16
references.pmid: 17261652
references.citation: Circulation. 2004 Jun 29;109(25):3171-5
references.pmid: 15184279
references.citation: J Am Coll Cardiol. 2005 Jun 7;45(11):1748-52
references.pmid: 15936599
references.citation: Eur Heart J. 2006 Oct;27(20):2420-5
references.pmid: 17005534
references.citation: Platelets. 2007 Nov;18(7):497-505
references.pmid: 17957565
references.citation: J Am Coll Cardiol. 2008 Apr 8;51(14):1404-11
references.pmid: 18387444
references.citation: J Am Coll Cardiol. 2005 May 3;45(9):1392-6
references.pmid: 15862408
references.citation: Platelets. 2006 Sep;17(6):385-92
references.pmid: 16973499
references.citation: J Am Coll Cardiol. 2006 Oct 3;48(7):1339-45
references.pmid: 17010792
references.citation: Circulation. 2005 Apr 26;111(16):2099-106
references.pmid: 15750189
references.citation: J Am Coll Cardiol. 2007 Jun 19;49(24):2312-7
references.pmid: 17572245
references.citation: J Am Coll Cardiol. 2005 Nov 15;46(10):1820-6
references.pmid: 16286165
references.citation: J Thromb Haemost. 2007 Sep;5(9):1839-47
references.pmid: 17723123
references.citation: Thromb J. 2008 Feb 29;6:1
references.pmid: 18312665
references.citation: J Thromb Haemost. 2006 Nov;4(11):2516-8
references.pmid: 16938130
references.citation: Am J Cardiol. 2006 Sep 1;98(5):681-4
references.pmid: 16923461
references.citation: Eur Heart J. 2004 Nov;25(21):1903-10
references.pmid: 15522469
references.citation: Thromb Haemost. 2008 Feb;99(2):409-15
references.pmid: 18278193
references.citation: J Am Coll Cardiol. 2005 Nov 15;46(10):1827-32
references.pmid: 16286166
references.citation: J Lab Clin Med. 2004 May;143(5):301-9
references.pmid: 15122174
references.citation: Circulation. 2005 Nov 8;112(19):2946-50
references.pmid: 16260639